Do you want to read an article? Please log in or register.
Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment
Anxiety and DepressionBipolar Disorder
Related content
Anxiety and DepressionBipolar Disorder
Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study
J Affect Disord.
Morlet E, Costemale-Lacoste JF, Poulet E, McMahon K, Hoertel N, Limosin F, CSA Study Group.
doi: 10.1016/j.jad.2019.08.056.
Aging and Cognitive FunctionsBipolar Disorder
Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study
Lancet Psychiatry.
Yatham LN, Mackala S, Basivireddy J, Ahn S, Walji N, Hu C, Lam RW, Torres IJ
doi: 10.1016/
Bipolar Disorder
Long-acting injectable antipsychotics as maintenance treatments for bipolar disorder-A critical review of the evidence
Bipolar Disord.
Boyce P, Irwin L, Morris G, Hamilton A, Mulder R, Malhi GS, Porter RJ
doi: 10.1111/bdi.12698.
Bipolar Disorder
Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study
Hum Psychopharmacol.
Musetti L, Tundo A, Benedetti A, Massimetti G, Cambiali E, Pergentini I, Del Grande C, Dell'Osso L
doi: 10.1002/hup.2676.
Migraine and HeadacheAnxiety and Depression
The safety and tolerability of cariprazine in patients with manic or mixed episodes associated with bipolar I disorder: A 16-week open-label study
J Affect Disord.
Ketter TA, Sachs GS, Durgam S, Lu K, Starace A, Laszlovszky I, Németh G
doi: 10.1016/
Anxiety and Depression
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
J Clin Psychiatry.
Wajs E, Aluisio L, Holder R, Daly EJ, Lane R, Lim P, George JE, Morrison RL, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, Hough D, Grunfeld J, Jeon HJ, Wilkinson ST, Drevets WC, Singh JB
doi: 10.4088/JCP.19m12891.
Further Publications Psychiatry
Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study
J Affect Disord
Ishigooka J, Kato T, Miyajima M, Watabe K, Masuda T, Hagi K, Higuchi T
doi: 10.1016/j.jad.2020.12.005
Epilepsy
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
O'Brien TJ, Borghs S, He QJ, Schulz AL, Yates S, Biton V
doi: 10.1111/epi.16484.
Bipolar Disorder
Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16,288 patients with bipolar disorder
Bipolar Disord.
Köhler-Forsberg O, Gasse C, Hieronymus F, Petersen L, Christensen RH, Nierenberg AA, Østergaard SD
doi: 10.1111/bdi.12976.